Search Results 1001-1010 of 17412 for monoclonal antibody
ROCHESTER, Minn. — A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can ...
... monoclonal antibodies, and not a candidate for ... antibody syndrome. Patients receiving dual ... antibody positive, confirmed by HCV ribonucleic acid).
... antibody must be negative for HCV RNA by PCR to be eligible for study participation ... Monoclonal and/or bispecific antibodies or CAR T - At least 28 days. 5 ...
Monoclonal antibodies: Subjects who have received any monoclonal antibody within 5 half-lives of Visit 1. Investigational medications: Subjects who have ...
... monoclonal antibody specific for the epithelial-cell-derived cytokine thymic stromal lymphopoietin (TSLP), in patients whose asthma remained uncontrolled ...
... monoclonal antibodies (Grade ≥ 3 National Cancer Institute [NCI]-Common ... antibody, or anti-4-1BB antibody is not allowed, inclusive of localized ...
Subjects enrolled in the PD-1-treatment-failure HNSCC cohort must be refractory to an FDA approved anti-PD-1/PD-L1 monoclonal antibody ... antibodies), or ...
History of severe hypersensitivity reaction to any monoclonal antibody. Other severe acute or chronic medical (including bone marrow suppressive diseases) ...
Use of anti-IgE (e.g., omalizumab) or any other monoclonal antibody, in the 6 months prior to randomization. Use of (Beta) β-blockers within 1 day prior to ...
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 31 to multiply your impact 3×.